A new test co-developed by a Boston University School of Medicine (BUSM) researcher will allow patients suspected of having lung cancer to be subjected to fewer and less-invasive tests to determine if they have the disease.  The team state that there is an increase in the number of lesions suspicious for lung cancer found on chest imaging of current and former smokers. In the past, … Continue reading Large-scale human trials validates the use of genomic-based test for lung cancer detection.